Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;39(1):180-183.
doi: 10.1007/s00464-024-11263-2. Epub 2024 Oct 29.

Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period

Affiliations

Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period

Tammy L Kindel et al. Surg Endosc. 2025 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Disclosures: Tammy Kindel and Anupama Wadhwa have no disclosures. Girish Joshi has received honoraria for consultation from Merck Sharpe and Dohme Inc. and Vertex Pharmaceuticals. Teresa LaMasters has received honoraria for consulting and speaking from WL Gore, Intuitive Surgical, Novo Nordisk, and Ethicon Endosurgical. Shauna Levy is a consultant for Novo Nordisk. Omar Ghanem is a consultant for Medtronic and Olympus. Allison Schulman is a consultant for Apollo Endosurgery, Boston Scientific, Olympus, MicroTech, Fractyl, and has received research/grant support from GI Dynamics and Fractyl. Andrew Wang discloses owning publicly traded stock in GE HealthCare Technologies and Pfizer. Reem Sharaiha is a consultant for Boston Scientific, Intuitive Surgical, and Olympus. Matthew Kroh is a consultant for Intuitive Surgical, Levita, and Momentis, and on the advisory board for Endolumik, Kintsugi, Medtronic and FastPathway.

References

    1. Blundell J, Finlayson G, Axelsen M et al (2017) Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab 19:1242–1251 - PMC - PubMed
    1. Nauck MA, Wollschläger D, Werner J et al (1996) Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Diabetologia 39:1546–1553 - PubMed
    1. Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ (1995) Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and healthy subjects. Diabetes 44:1126–1131 - PubMed
    1. Joshi GP, Abdelmalak BB, Weigel WA, et al (2023) American society of anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. Accessed 10 Feb 2024 https://www.asahq.org/aboutasa/newsroom/news-releases/2023/06/american-s...
    1. Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al (2023) Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth 87:111091 - PubMed

LinkOut - more resources